← Back to Search

LY3473329 for Healthy Subjects

Phase 1
Waitlist Available
Research Sponsored by Eli Lilly and Company
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up predose on day 1 through day 43
Awards & highlights

Summary

This trial tests a new drug, LY3473329, in healthy Japanese participants to see if it is safe and how the body handles it. Researchers will measure how quickly it enters the bloodstream and how long it stays in the body.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~predose on day 1 through day 43
This trial's timeline: 3 weeks for screening, Varies for treatment, and predose on day 1 through day 43 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of Participants with One or More Treatment Emergent Adverse Events (TEAEs) and Serious Adverse Event(s) (SAEs) Considered by the Investigator to be Related to Study Drug Administration
Secondary study objectives
PK: Maximum Concentration (Cmax) of LY3473329
PK: Time to Maximum Concentration (Tmax) of LY3473329
Pharmacokinetics (PK): Area Under the Concentration Versus Time Curve (AUC) of LY3473329

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: LY3473329Experimental Treatment1 Intervention
LY3473329 administered orally.
Group II: PlaceboPlacebo Group1 Intervention
Placebo administered orally.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
LY3473329
2021
Completed Phase 2
~360

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Eli Lilly and CompanyLead Sponsor
2,640 Previous Clinical Trials
3,221,620 Total Patients Enrolled
Study DirectorEli Lilly and Company
1,358 Previous Clinical Trials
418,066 Total Patients Enrolled
~6 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top